Atlas FDA

Belotero Balance Dermal Filler, Belotero Balance + Lidocaine Dermal Filler

FDA premarket approval P090016/S042 · decided 2020-12-22

Approval details

PMA number
P090016
Supplement
S042
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Belotero Balance Dermal Filler, Belotero Balance + Lidocaine Dermal Filler
Generic name
Implant, dermal, for aesthetic use
Applicant
Merz North America, Inc.
Date received
2020-06-23
Decision date
2020-12-22
Days to decision
182 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Franksville, WI
Statement
Approval for the addition of new release and shelf-life specifications for rheology and a change to the existing release and shelf-life specifications for ejection force for Belotero Balance Dermal Filler and Belotero Balance + Lidocaine Dermal Filler.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DESCRIBE PFD Patch (K172689)Merz North America, Inc.2017-11-29